Carolina Gutierrez
Overview
Explore the profile of Carolina Gutierrez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
105
Citations
3719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Veeraraghavan J, De Angelis C, Gutierrez C, Liao F, Sabotta C, Rimawi M, et al.
Adv Exp Med Biol
. 2025 Jan;
1464():495-525.
PMID: 39821040
HER2-positive (+) breast cancer is an aggressive disease with poor prognosis, a narrative that changed drastically with the advent and approval of trastuzumab, the first humanized monoclonal antibody targeting HER2....
2.
Sedorko D, Gutierrez C, Pazos P, Nebelsick J, Weinschutz L, Garcia M, et al.
An Acad Bras Cienc
. 2024 Dec;
96(suppl 2):e20240627.
PMID: 39699399
This study investigates ichnoassemblages characterized by spreite trace fossils from the Upper Cretaceous Snow Hill Island Formation on Vega Island, Antarctica. The succession reveals alternating heterolithic beds of sandy siltstones...
3.
Gutierrez C, Uhlig-Reche H, Mones M, Rivera-Davila M, Prakash S, Aldrich M
South Med J
. 2024 Nov;
117(11):666-668.
PMID: 39486453
Objective: Lymphedema commonly affects females with Turner syndrome (TS), although it may be underrecognized and untreated. The objective of this study was to better understand self-reported lymphedema prevalence, knowledge, and...
4.
Calfunao S, Carrasco M, Gutierrez C, Cerpa L, Varela N, Quinones L
Rev Med Chil
. 2024 Aug;
151(10):1375-1384.
PMID: 39093141
Siponimod is a selective immunosuppressive medication, developed as the first oral therapy for active secondary progressive multiple sclerosis. This medication acts by modulating the sphingosine 1 phosphate (S1P) receptor, as...
5.
Johnson K, Gardener H, Gutierrez C, Marulanda E, Campo-Bustillo I, Gordon Perue G, et al.
J Stroke Cerebrovasc Dis
. 2024 Jul;
33(9):107842.
PMID: 38955245
Objectives: We explore patient-reported behaviors and activities within 30-days post-stroke hospitalization and their role in reducing death or readmissions within 90-days post-stroke. Methods: We constructed the adequate transitions of care...
6.
Munoz-Caicedo B, Garcia-Gomez V, Gutierrez C, Norena-Rengifo B, Munoz-Caicedo J
Cureus
. 2024 Apr;
16(3):e55351.
PMID: 38559534
Anastomosing hemangioma is a rare and benign subtype of capillary hemangioma, a soft tissue tumor. It tends to be asymptomatic, causes abdominal pain and hematuria, and is more common in...
7.
Cheng J, Ramos Emos M, Leite V, Capozzi L, Woodrow L, Gutierrez C, et al.
Am J Phys Med Rehabil
. 2024 Feb;
103(3S Suppl 1):S62-S71.
PMID: 38364033
Objective: The aim of the study is to identify and appraise current evidence for rehabilitation interventions in head and neck cancer. Design: A previously published scoping review spanning 1990 through...
8.
Aguareles J, Villares Fernandez P, Carralon-Gonzalez M, Forne Izquierdo C, Marti-Ballesteros E, Pradillo Fernandez V, et al.
Int J Infect Dis
. 2023 Jul;
135:12-17.
PMID: 37481109
Objectives: To evaluate the compassionate use of plitidepsin as an antiviral treatment in hospitalized immunocompromised adult patients with moderate-to-severe COVID-19. Design: Retrospective observational study of data -collected from January 01,...
9.
Fu X, Pereira R, Liu C, De Angelis C, Shea M, Nanda S, et al.
Cell Rep
. 2023 Jul;
42(8):112821.
PMID: 37467106
Aberrant activation of the forkhead protein FOXA1 is observed in advanced hormone-related cancers. However, the key mediators of high FOXA1 signaling remain elusive. We demonstrate that ectopic high FOXA1 (H-FOXA1)...
10.
De Gregorio M, Guirola J, Serrano-Casorran C, Urbano J, Gutierrez C, Gregorio A, et al.
Eur Radiol
. 2023 Jul;
33(12):8754-8763.
PMID: 37458757
Objectives: To evaluate the safety and efficacy of catheter-directed hemorrhoidal embolization (CDHE) by microcoil embolization for rectal bleeding due to hemorrhoids classified as Goligher grade I-III. Methods: Eighty patients (62.5%...